首页|超声引导下射频消融治疗子宫腺肌症的临床疗效分析

超声引导下射频消融治疗子宫腺肌症的临床疗效分析

扫码查看
目的 探讨对子宫腺肌症采用超声引导下射频消融治疗的临床疗效。方法 40 例子宫腺肌症患者,以随机数字表法分为对照组和观察组,各 20 例。对照组患者采用药物保守治疗,观察组患者在药物保守治疗基础上采用超声引导下射频消融治疗。比较两组临床疗效,病灶与子宫体积、子宫内膜厚度,痛经、经量及贫血情况,复发风险[糖链抗原(CA)125 及血管内皮生长因子(VEGF)水平]。结果 观察组总有效率 95。00%高于对照组的 65。00%(P<0。05)。治疗 3 个月后,两组子宫与病灶体积较本组治疗前缩小,子宫内膜厚度较本组治疗前降低,且观察组子宫体积(92。57±14。28)cm3、病灶体积(42。36±10。55)cm3 小于对照组的(132。48±16。31)、(64。47±12。31)cm3,子宫内膜厚度(5。72±0。74)mm低于对照组的(6。84±0。95)mm(P<0。05)。治疗 3 个月后,两组疼痛评分、月经失血图法评分较本组治疗前降低,血红蛋白水平较本组治疗前升高,且观察组疼痛评分(2。62±0。74)分、月经失血图法评分(69。51±10。26)分低于对照组的(3。28±0。95)、(85。77±14。41)分,血红蛋白水平(115。37±13。15)g/L高于对照组的(104。46±12。87)g/L(P<0。05)。治疗 3 个月后,两组CA125、VEGF水平均较本组治疗前降低,且观察组CA125(30。45±17。53)IU/ml、VEGF(117。25±12。83)ng/L低于对照组的(72。31±21。04)IU/ml、(139。61±15。25)ng/L(P<0。05)。结论 对子宫腺肌症采用超声引导下射频消融治疗疗效确切,能改善痛经、月经紊乱及贫血情况,降低复发风险。
Analysis of clinical efficacy of ultrasound-guided radiofrequency ablation on adenomyosis
Objective To explore the clinical efficacy of ultrasound-guided radiofrequency ablation on adenomyosis.Methods 40 patients with adenomyosis were divided into a control group and an observation group by random number table method,with 20 cases in each group.The control group received conservative drug treatment,and the observation group received ultrasound-guided radiofrequency ablation on the basis of conservative drug treatment.The clinical efficacy,lesion and uterine volume,endometrial thickness,dysmenorrhea,menstrual volume and anemia,risk of recurrence[carbohydrate antigen(CA)125 and vascular endothelial growth factor(VEGF)levels]were compared between the two groups.Results The total effective rate of the observation group was 95.00%,which was higher than 65.00%of the control group(P<0.05).After 3 months of treatment,the uterine volume and lesion volume in both groups were smaller than those before treatment,and the endometrial thickness was lower than that before treatment;the uterine volume of(92.57±14.28)cm3 and lesion volume of(42.36±10.55)cm3 in the observation group were smaller than(132.48±16.31)and(64.47±12.31)cm3 in the control group;the endometrial thickness of(5.72±0.74)mm in the observation group was lower than(6.84±0.95)mm in the control group(P<0.05).After 3 months of treatment,the pain score and pictorial blood loss assessment chart score of the two groups were lower than those before treatment,and the hemoglobin level was higher than that before treatment;the pain score of the observation group was(2.62±0.74)points,and the pictorial blood loss assessment chart score was(69.51±10.26)points,which were lower than(3.28±0.95)and(85.77±14.41)points of the control group;the hemoglobin level of(115.37±13.15)g/L of the observation group was higher than(104.46±12.87)g/L of the control group(P<0.05).After 3 months of treatment,the levels of CA125 and VEGF in both groups were lower than those before treatment;the observation group had CA125 of(30.45±17.53)IU/ml and VEGF of(117.25±12.83)ng/L,which were lower than(72.31±21.04)IU/ml and(139.61±15.25)ng/L in the control group(P<0.05).Conclusion Ultrasound-guided radiofrequency ablation is effective in treating adenomyosis,which can improve dysmenorrhea,menstrual disorder and anemia and reduce the risk of recurrence.

Ultrasound guidanceRadiofrequency ablationAdenomyosisConservative treatmentDysmenorrheaRecurrence

李凤英

展开 >

272200 金乡县人民医院超声科

超声引导 射频消融 子宫腺肌症 保守治疗 痛经 复发

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(15)